Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — Strategic Asset Allocation Index
Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a Strategic Asset Allocation Index of 18.7% as of June 2023. Strategic assets (PP&E of CN¥1.23 Billion plus long-term investments of CN¥-) total CN¥1.23 Billion, measured against net assets of CN¥6.61 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Nanjing King-friend Biochemical Pharmace to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Strategic Asset Allocation Index (2014–2021)
This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2014 to 2021. As of June 2023, the index stands at 18.7%, representing strategic assets of CN¥1.23 Billion against net assets of CN¥6.61 Billion CNY. For live market cap and overall valuation, see 603707 stock market capitalisation.
Annual Strategic Asset Allocation Index for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2014–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2014 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 603707 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.3% | CN¥827.42 Million | CN¥827.42 Million | CN¥- | CN¥5.40 Billion | ▲ +1.1 pp |
| 2020 | 14.2% | CN¥532.83 Million | CN¥532.83 Million | CN¥- | CN¥3.74 Billion | ▼ -1.8 pp |
| 2019 | 16.0% | CN¥481.46 Million | CN¥481.46 Million | CN¥- | CN¥3.00 Billion | ▼ -3.4 pp |
| 2018 | 19.5% | CN¥471.23 Million | CN¥471.23 Million | CN¥- | CN¥2.42 Billion | ▼ -0.2 pp |
| 2017 | 19.6% | CN¥402.66 Million | CN¥402.66 Million | CN¥- | CN¥2.05 Billion | ▼ -10.7 pp |
| 2016 | 30.3% | CN¥398.85 Million | CN¥398.85 Million | CN¥- | CN¥1.31 Billion | ▲ +2.6 pp |
| 2015 | 27.7% | CN¥302.74 Million | CN¥302.74 Million | CN¥- | CN¥1.09 Billion | ▲ +1.4 pp |
| 2014 | 26.3% | CN¥271.80 Million | CN¥271.80 Million | CN¥- | CN¥1.03 Billion | — |